Magnetismm-1: Phase 1 Study Of Elranatamab (Pf-06863135), A B-Cell Maturation Antigen (Bcma) Targeted Cd3-Engaging Bispecific Antibody, For Patients With Relapsed Or Refractory Multiple Myeloma (Mm)
Elranatamab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Magnetismm-1: Phase 1 Study Of Elranatamab (Pf-06863135), A B-Cell Maturation Antigen (Bcma) Targeted Cd3-Engaging Bispecific Antibody, For Patients With Relapsed Or Refractory Multiple Myeloma (Mm) ### Output: Elranatamab